Related Articles
Potential signaling pathways as therapeutic targets for overcoming chemoresistance in mucinous ovarian cancer (Review)
Emerging biomarkers of prostate cancer (Review)
Cystatin B is a progression marker of human epithelial ovarian tumors mediated by the TGF-β signaling pathway
Checkpoint kinase 1 inhibitors as targeted molecular agents for clear cell carcinoma of the ovary (Review)
Malignant neoplasia arising from ovarian remnants following bilateral salpingo‑oophorectomy (Review)